Anyone have any theories on this offer from Hospira?
JAV has quite a bit going on these days and today's recall news in the UK has the ticker plunging by 30% to 52 week lows.
They terminated an agreement with MYRX...have an offer on the table for $2.20 from HSP and also have an FDA approval pending in October.
I have a small long bet at $1.19. Trying to learn more...
Brands associated with print news have certainly taken their share of lumps over the past few years and rightfully so. Media is evolving and many print-centric brands will continue to fall by the wayside. There will always be a place for quality content however and I think we will see more partnerships fostering best of breed technology with world class content. [more]
I am not posting here to try to provoke the bears as they emerge from a long and painful hiberation. Admittedly I came to the party late (August) and have seen most gains wiped out in just a few days. It has been discouraging, emotional and has caused me to reflect on my connection with the market. [more]
Looking to add a little to Pharma after the AZN buy and the choice was down to PFE, JNJ, ABT, GILD and FRX. The first 3 for dividends and the latter 2 for potential value. [more]
The funnel cloud known as SmartHeat has drawn in another victim. It has been over a month since they disappointed the street and have been paying dearly ever since. [more]